Similar articles

• Re: Breast cancer gene microarrays pass muster.

  Shak S, Palmer G, Baker J. Shak S, et al. J Natl Cancer Inst. 2007 Apr 4;99(7):572-3. doi: 10.1093/jnci/djk118. J Natl Cancer Inst. 2007. PMID: 17406004 No abstract available.
• Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?

  Correa Geyer F, Reis-Filho JS. Correa Geyer F, et al. Int J Surg Pathol. 2009 Aug;17(4):285-302. doi: 10.1177/1066896908328577. Epub 2008 Dec 22. Int J Surg Pathol. 2009. PMID: 19103611 Review.
• [Gene expression profiles in the diagnosis and prognosis of cancer].

  Kopper L, Tímár J. Kopper L, et al. Magy Onkol. 2002;46(1):3-9. Epub 2003 Feb 3. Magy Onkol. 2002. PMID: 12050676 Review. Hungarian.
• Molecular assays to predict prognosis of breast cancer.

  Paik S. Paik S. Clin Adv Hematol Oncol. 2007 Sep;5(9):681-2. Clin Adv Hematol Oncol. 2007. PMID: 17982408 Review. No abstract available.
• Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.

  Malinowski DP. Malinowski DP. Expert Rev Mol Diagn. 2007 May;7(3):269-80. doi: 10.1586/14737159.7.3.269. Expert Rev Mol Diagn. 2007. PMID: 17489734 Review.